To investigate long-acting PrEP formulations in macaque subjects.

To engage partners and stakeholders on awareness and education for infection associated chronic conditions (IACC).

To engage communities through the power of arts and culture to educate, empower and mobilize individuals toward positive change. Thriving Together Atlanta serves as a model of how cross-sector partnerships can address multifaceted issues affecting communities today.

To build community resilience against weather events by supporting local disaster preparedness programs through community-based organizations in the Midwest, with a focus on rural areas.

To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.

To provide project management services to include management of design and performance by CDC of an animal research study involving application of microarray patches (MAPs) containing antiretrovirals for HIV treatment to rhesus macaques.

To complete the Zika Contraceptive Access Network (Z-CAN) through data collection, evaluation and dissemination.

To provide travel support for onsite technical assistance to countries conducting various rotavirus studies.

To enable veterinary students from across the United States, Canada and the Caribbean to learn more about opportunities in public health for veterinary professionals.

To optimize interventions and tools to enable the elimination and eradication of prioritized Neglected Tropical Diseases (NTDs) as identified by the London Declaration.

To support key initiatives addressing typhoid and cholera including the evaluation manuscript of the pilots of the Burden and Risk Assessment in Typhoid (BRAT) framework, the implementation of the BRAT tool in real-world settings and the development of a manuscript on vaccination strategies in conflict settings.

To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.